Population Health

The authors, from RxCrossroads by McKesson, discuss the impact of copay accumulator and maximizer programs.

A new national study is highlighting disparities in morbidity and barriers to care that face patients with chronic obstructive pulmonary disease (COPD) living in in rural areas.

The US death toll is above average for the previous 5 months; childhood obesity is on the rise among children of color and low-income families; the debate on using e-cigarettes for smoking cessation.

Temporarily halting a trial to evaluate a vaccine means we are following the rules of safety, noted Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing.

Addressing gaps in testing and education within precision oncology can assist in improving access to patients of color and other underserved populations.

A House panel found pharmaceutical companies exponentially increased drug prices to boost profits; CDC data show an increase in alcohol-related deaths, especially among women; 4 million more Americans enroll in Medicaid.

The authors detail how population health management enables health systems to promote public health, strengthen health system resiliency, and support financial recovery during and beyond coronavirus disease 2019 (COVID-19).

The study is part of Moderna’s larger trial to find a vaccine to prevent coronavirus disease 2019, which puts older adults, who have weaker immune responses, at a higher risk of more severe illness and death.

HHS said it will send 100 million rapid COVID-19 tests to states by year’s end; CDC says teens twice as likely to get coronavirus infection than young children; several private health insurers to stop waiving telehealth copays.

The announcement comes just 6 weeks before the Supreme Court is set to hear oral arguments in Texas v Azar, upon which the future of the Affordable Care Act (ACA)—which counts among its many provisions protection for patients with preexisting conditions—hinges, and which the administration is trying to get overturned.

Vaccine safety and effectiveness are patients’ biggest concerns about a potential coronavirus disease 2019 (COVID-19) vaccine, says Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing.

The authors used health care claims and survey data to identify a strategy that might promote life satisfaction while advancing equity in an insured population.

To mark the 25th anniversary of the journal, each issue in 2020 will include a special feature: an interview with a thought leader in the world of health care and medicine. The September issue features a conversation with Georges C. Benjamin, MD, executive director of the American Public Health Association.

Transitioning from population to precision health care, as well as eschewing old health care models of the past linked with misuse and excess cost, can assist in evolving the current US health care delivery system.

Nineteen bioethicists proposed a 3-phase plan for equitable distribution of a vaccine for coronavirus disease 2019 (COVID-19).

In this episode of Managed Care Cast, we talk with Michael N. Abrams, a cofounder and managing partner of Numerof & Associates, about the fifth annual report on the state of population health.

Preliminary data find Moderna's COVID-19 vaccine effective in older adults; FDA authorizes use of $5 COVID-19 rapid test; the DOJ asks for nursing home data from 4 blue states.

Two days after the CDC changed its guidance on who should get tested for SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), HHS said the move was not politically motivated.

Until a vaccine is available, antibody tests may offer the best way to assess risk prevalence and community spread of COVID-19.

Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, spoke recently with The American Journal of Managed Care®. During the interview, we asked about health burdens that disproportionately affect Black and other multiracial US communities.

In this episode of Managed Care Cast, we share a little bit of our forthcoming interview with Georges C. Benjamin, MD, executive director of the American Public Health Association, which will appear in the September issue of The American Journal of Managed Care®.

A move by HHS to allow pharmacists to give childhood vaccinations draws criticism from the American Academy of Pediatrics.

Through the partnership between Innovaccer and Emtiro Health, data utilization will work to delineate and address social aspects known to affect the health of populations nationwide, said Kelly Garrison, CEO at Emtiro Health, and Paul Grundy, MD, chief transformation officer at Innovaccer.

Patricia Salber, MD, MBA, of The Doctor Weighs In, and Scott Hayworth, MD, president and CEO of New York-based CareMount Medical, discuss delivering preventive care and managing chronic illnesses during the coronavirus disease 2019 (COVID-19) pandemic.

When a crisis hits and members become isolated, how can a health plan continue to play an active role in maintaining their health?

AJMC interviews Jill A. Fisher, PhD, author of a new book, Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals. Her research took her inside clinical testing sites for phase 1 drug studies.

From 1968 to 2016, differences among Black and White older adults’ mortality rates have narrowed in urban areas of America. However, data show a considerable widening in the mortality rate among Black and White men living in rural counties.

Robin Gelburd, JD, president of FAIR Health, discusses telehealth growth in May medical claims.

The coronavirus disease 2019 (COVID-19) vaccines that are leading the pack are utilizing a new vaccine technology that has never been approved for human use by the FDA. As a result, there are a lot of unknowns.

All patients with cancer deserve a fair shot at survival, and this includes access to clinical trials. At present, however, access to these trials is restricted under Medicaid coverage, necessitating a need for change at the federal policy level, noted Fumiko Chino, MD, assistant attending radiation oncologist at Memorial Sloan Kettering Cancer Center in New York, in an interview for ASCO20 Virtual, this year’s annual meeting of the American Society of Clinical Oncology.